InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Karl Mahler, Executive. Director active across 1 company, notably Marinomed Biotech AG. Aggregated, 2 filings have been recorded. Activity tracked since 8 January 2025. The latest transaction was filed on 31 March 2026 (Other). Regulator: FMA (OeKB OAM). All data is free.
Declarations2 total
1,500 shares@ €14.000.079% mcap50.0% of flowShareFMA:247198
●
1,500 shares@ €14.000.079% mcap50.0% of flowShareFMA:216982
Ideal exit: 5 Oct 2025 (T+270)
2 of 2 declarations
About Karl Mahler
Karl Mahler is an Executive at Marinomed Biotech AG. In this role, he is involved in the strategic management of the company and contributes to key decision-making. His experience in the biopharmaceutical sector allows him to play a crucial role in the direction and growth of Marinomed. Karl is committed to promoting sustainable and responsible practices.
